Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant

PHASE3RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 8, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions

Sleep Wake DisordersSleep Disorders, Circadian RhythmChronobiology DisordersGene Mutations and Other Alterations Nec

Interventions

DRUG

Tasimelteon

Oral capsule

DRUG

Placebo

Oral capsule

Trial Locations (1)

RECRUITING

Vanda Investigational Site, Çankaya